Latest

Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆

Updated 26 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Sutton

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

11

Recruiting now

13

Studies tracked

Sutton

Selected city

Recruiting Phase 3

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer
Novartis Pharmaceuticals · started 2025-07-01

📍 Sutton · London

NCT06855277 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
AbbVie · started 2025-04-24

📍 London · Oxford · Sutton · Manchester

NCT06820463 on ClinicalTrials.gov ↗

Active Phase 1

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

Neoplasms
Tesaro, Inc. · started 2016-03-07

📍 Newcastle upon Tyne · Aberdeen · London · Manchester · Oxford

NCT02715284 on ClinicalTrials.gov ↗

Recruiting Phase 1

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Solid Tumor
Genentech, Inc. · started 2024-11-14

📍 Edinburgh · London · Manchester · Sutton

NCT06619587 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC · started 2025-09-02

📍 Birmingham · London · Manchester · Sutton

NCT07164443 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Merck Sharp & Dohme LLC · started 2025-04-09

📍 Cambridge · Edinburgh · Preston · London · Sutton

NCT06824467 on ClinicalTrials.gov ↗

Active Phase 1

AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies

Tumor, Cancer
AstraZeneca · started 2007-03-08

📍 Sutton

NCT00463814 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Relapsed/Refractory Multiple Myeloma
BeOne Medicines · started 2021-09-16

📍 Headington · London · Sutton · Truro

NCT04973605 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Non-Small Cell Lung Cancer (NSCLC)
Amgen · started 2023-11-16

📍 Birmingham · Inverness · London · Northwood · Nottingham

NCT05920356 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC · started 2025-05-13

📍 Cambridge · London · Exeter · Birmingham · Northwood

NCT06925737 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals · started 2025-10-15

📍 Sutton · London

NCT07206056 on ClinicalTrials.gov ↗

Recruiting Phase 3

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Metastatic Colorectal Cancer
Amgen · started 2024-07-17

📍 Birmingham · Glasgow · London · Maidstone · Northwood

NCT06252649 on ClinicalTrials.gov ↗

Recruiting Phase 3

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Non-small Cell Lung Cancer
Boehringer Ingelheim · started 2026-01-16

📍 Cardiff · Edinburgh · London · Manchester · Sutton

NCT07195695 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 111 Manchester · 39 Cambridge · 36 Birmingham · 32 Glasgow · 25 Bristol · 23 Edinburgh · 23 Oxford · 22 Sheffield · 21 Newcastle upon Tyne · 20 Leicester · 17 Liverpool · 16 Leeds · 16 Sutton · 13 Truro · 13 Aberdeen · 12

Browse by condition

Chronic Lymphocytic Leukemia · 5 Prostate Cancer · 4 Breast Cancer · 3 Non-small Cell Lung Cancer · 3 Healthy · 3 Ulcerative Colitis · 3 Crohn's Disease · 3 Advanced Solid Tumor · 3 Multiple Myeloma · 3 Neoplasm Metastasis · 3 Heart Failure · 3 Hypertension · 2 Metastatic Colorectal Cancer · 2 Obesity or Overweight · 2 Diabetes Mellitus, Type 2 · 2 Graves' Disease · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/sutton (Accessed: 26 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.